ReP USP - Resultado da busca

Artigo de periodico
Determination of serum levels of imatinib mesylate in patients with chronic myeloid leukemia: validation and application of a new analytical method to monitor treatment compliance (2013)
Rezende, Vinícius Marcondes; Rivellis, Ariane Julio; Gomes, Melissa Medrano; Dörr, Felipe Augusto; Novaes, Mafalda Megumi Yoshinaga; Nardinelli, Luciana; Costa, Ariel Lais de Lima; Chamone, Dalton de Alencar Fisher; Bendit, Israel
Source: Revista brasileira de hematologia e hemoterapia. Unidades: FM, FCF
Subjects: LEUCEMIA MIELOIDE, DOENÇA CRÔNICA, MONITORIZAÇÃO FISIOLÓGICA, ANTINEOPLÁSICOS (ADMINISTRAÇÃO E DOSAGEM), CROMATOGRAFIA LÍQUIDA, CROMATOGRAFIA LÍQUIDA DE ALTA EFICIÊNCIA, ESPECTROMETRIA DE MASSAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
REZENDE, Vinícius Marcondes et al. Determination of serum levels of imatinib mesylate in patients with chronic myeloid leukemia: validation and application of a new analytical method to monitor treatment compliance. Revista brasileira de hematologia e hemoterapia, v. 35, n. 2, p. 103-108, 2013Tradução . . Disponível em: https://doi.org/10.5581/1516-8484.20130030. Acesso em: 05 nov. 2024.
APA
Rezende, V. M., Rivellis, A. J., Gomes, M. M., Dörr, F. A., Novaes, M. M. Y., Nardinelli, L., et al. (2013). Determination of serum levels of imatinib mesylate in patients with chronic myeloid leukemia: validation and application of a new analytical method to monitor treatment compliance. Revista brasileira de hematologia e hemoterapia, 35( 2), 103-108. doi:10.5581/1516-8484.20130030
NLM
Rezende VM, Rivellis AJ, Gomes MM, Dörr FA, Novaes MMY, Nardinelli L, Costa AL de L, Chamone D de AF, Bendit I. Determination of serum levels of imatinib mesylate in patients with chronic myeloid leukemia: validation and application of a new analytical method to monitor treatment compliance [Internet]. Revista brasileira de hematologia e hemoterapia. 2013 ; 35( 2): 103-108.[citado 2024 nov. 05 ] Available from: https://doi.org/10.5581/1516-8484.20130030
Vancouver
Rezende VM, Rivellis AJ, Gomes MM, Dörr FA, Novaes MMY, Nardinelli L, Costa AL de L, Chamone D de AF, Bendit I. Determination of serum levels of imatinib mesylate in patients with chronic myeloid leukemia: validation and application of a new analytical method to monitor treatment compliance [Internet]. Revista brasileira de hematologia e hemoterapia. 2013 ; 35( 2): 103-108.[citado 2024 nov. 05 ] Available from: https://doi.org/10.5581/1516-8484.20130030
Artigo de periodico
Pretherapeutic Expression of the hOCT1 Gene Predicts a Complete Molecular Response to Imatinib Mesylate in Chronic-Phase Chronic Myeloid Leukemia (2012)
Nardinelli, Luciana; Sanabani, Sabri Saeed; Didone, Alline; Ferreira, Patricia de Barros; Serpa, Mariana; Novaes, Mafalda Megumi Yoshinaga; Marchiani, Mariana; Ruiz, Antonio Lancha; Lima, Ismael Severino; Chamone, Dalton de Alencar Fischer; Bendit, Israel
Source: Acta Haematologica. Unidade: FM
Subjects: EXPRESSÃO GÊNICA, DOENÇA CRÔNICA, BIOLOGIA MOLECULAR, LEUCEMIA MIELOIDE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NARDINELLI, Luciana et al. Pretherapeutic Expression of the hOCT1 Gene Predicts a Complete Molecular Response to Imatinib Mesylate in Chronic-Phase Chronic Myeloid Leukemia. Acta Haematologica, v. 127, n. 4, p. 228-234, 2012Tradução . . Disponível em: http://content.karger.com/ProdukteDB/produkte.asp?doi=10.1159/000336610. Acesso em: 05 nov. 2024.
APA
Nardinelli, L., Sanabani, S. S., Didone, A., Ferreira, P. de B., Serpa, M., Novaes, M. M. Y., et al. (2012). Pretherapeutic Expression of the hOCT1 Gene Predicts a Complete Molecular Response to Imatinib Mesylate in Chronic-Phase Chronic Myeloid Leukemia. Acta Haematologica, 127( 4), 228-234. doi:10.1159/000336610
NLM
Nardinelli L, Sanabani SS, Didone A, Ferreira P de B, Serpa M, Novaes MMY, Marchiani M, Ruiz AL, Lima IS, Chamone D de AF, Bendit I. Pretherapeutic Expression of the hOCT1 Gene Predicts a Complete Molecular Response to Imatinib Mesylate in Chronic-Phase Chronic Myeloid Leukemia [Internet]. Acta Haematologica. 2012 ; 127( 4): 228-234.[citado 2024 nov. 05 ] Available from: http://content.karger.com/ProdukteDB/produkte.asp?doi=10.1159/000336610
Vancouver
Nardinelli L, Sanabani SS, Didone A, Ferreira P de B, Serpa M, Novaes MMY, Marchiani M, Ruiz AL, Lima IS, Chamone D de AF, Bendit I. Pretherapeutic Expression of the hOCT1 Gene Predicts a Complete Molecular Response to Imatinib Mesylate in Chronic-Phase Chronic Myeloid Leukemia [Internet]. Acta Haematologica. 2012 ; 127( 4): 228-234.[citado 2024 nov. 05 ] Available from: http://content.karger.com/ProdukteDB/produkte.asp?doi=10.1159/000336610
Artigo de periodico
Evaluation of Long-Term Outcomes, Cytogenetic and Molecular Responses with Imatinib Mesylate in Early and Late Chronic-Phase Chronic Myeloid Leukemia: A Report from a Single Institute (2012)
Bendit, Israel; Sanabani, Sabri Saeed; Conchon, Monika; Serpa, Mariana; Novaes, Mafalda Megumi Yoshinaga; Nardinelli, Luciana; Pereira, Thales Dalessandro Meneguin; Tucunduva, Luciana; Ferreira, Patricia de Barros; Dorlhiac-Llacer, Pedro Enrique; Chamone, Dalton de Alencar Fischer
Source: Acta Haematologica. Unidade: FM
Subjects: CITOGENÉTICA MOLECULAR (AVALIAÇÃO), DOENÇA CRÔNICA, INTERFERONS, FASES, LEUCEMIA MIELOIDE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BENDIT, Israel et al. Evaluation of Long-Term Outcomes, Cytogenetic and Molecular Responses with Imatinib Mesylate in Early and Late Chronic-Phase Chronic Myeloid Leukemia: A Report from a Single Institute. Acta Haematologica, v. 128, n. 4, p. 223-232, 2012Tradução . . Disponível em: http://content.karger.com/ProdukteDB/produkte.asp?doi=10.1159/000339696. Acesso em: 05 nov. 2024.
APA
Bendit, I., Sanabani, S. S., Conchon, M., Serpa, M., Novaes, M. M. Y., Nardinelli, L., et al. (2012). Evaluation of Long-Term Outcomes, Cytogenetic and Molecular Responses with Imatinib Mesylate in Early and Late Chronic-Phase Chronic Myeloid Leukemia: A Report from a Single Institute. Acta Haematologica, 128( 4), 223-232. doi:10.1159/000339696
NLM
Bendit I, Sanabani SS, Conchon M, Serpa M, Novaes MMY, Nardinelli L, Pereira TDM, Tucunduva L, Ferreira P de B, Dorlhiac-Llacer PE, Chamone D de AF. Evaluation of Long-Term Outcomes, Cytogenetic and Molecular Responses with Imatinib Mesylate in Early and Late Chronic-Phase Chronic Myeloid Leukemia: A Report from a Single Institute [Internet]. Acta Haematologica. 2012 ; 128( 4): 223-232.[citado 2024 nov. 05 ] Available from: http://content.karger.com/ProdukteDB/produkte.asp?doi=10.1159/000339696
Vancouver
Bendit I, Sanabani SS, Conchon M, Serpa M, Novaes MMY, Nardinelli L, Pereira TDM, Tucunduva L, Ferreira P de B, Dorlhiac-Llacer PE, Chamone D de AF. Evaluation of Long-Term Outcomes, Cytogenetic and Molecular Responses with Imatinib Mesylate in Early and Late Chronic-Phase Chronic Myeloid Leukemia: A Report from a Single Institute [Internet]. Acta Haematologica. 2012 ; 128( 4): 223-232.[citado 2024 nov. 05 ] Available from: http://content.karger.com/ProdukteDB/produkte.asp?doi=10.1159/000339696
Trabalho de evento-resumo periodico
Chronic myeloid leukemia patients present elevation of the circulating endothelial cells (2008)
Godoy, Carla Rosa Teixeira; Meireles, Ana Luiza Langanke Pedroso; Chamone, Dalton; Brocardo, G. A.; Pereira, J.
Source: Blood. Conference titles: ASH Annual Meeting of American Society of Hematology. Unidade: FM
Subjects: DOENÇA CRÔNICA, LEUCEMIA (ETIOLOGIA), NEOVASCULARIZAÇÃO PATOLÓGICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GODOY, Carla Rosa Teixeira et al. Chronic myeloid leukemia patients present elevation of the circulating endothelial cells. Blood. New York: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 05 nov. 2024. , 2008
APA
Godoy, C. R. T., Meireles, A. L. L. P., Chamone, D., Brocardo, G. A., & Pereira, J. (2008). Chronic myeloid leukemia patients present elevation of the circulating endothelial cells. Blood. New York: Faculdade de Medicina, Universidade de São Paulo.
NLM
Godoy CRT, Meireles ALLP, Chamone D, Brocardo GA, Pereira J. Chronic myeloid leukemia patients present elevation of the circulating endothelial cells. Blood. 2008 ; 112 3.[citado 2024 nov. 05 ]
Vancouver
Godoy CRT, Meireles ALLP, Chamone D, Brocardo GA, Pereira J. Chronic myeloid leukemia patients present elevation of the circulating endothelial cells. Blood. 2008 ; 112 3.[citado 2024 nov. 05 ]
Artigo de periodico
Alcoholic intake predisposes to more interface hepatitis in chronic hepatitis C (2005)
Ribeiro, Maria de Fatima Gomes de Sa; Gayotto, Luiz Carlos da Costa; Chamone, Dalton de Alencar Fischer; Strauss, Edna
Source: Annals of Hepatology. Unidade: FM
Subjects: VÍRUS DA HEPATITE C, HEPATITE C (TRANSMISSÃO), DOENÇA CRÔNICA, TRANSFUSÃO DE SANGUE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RIBEIRO, Maria de Fatima Gomes de Sa et al. Alcoholic intake predisposes to more interface hepatitis in chronic hepatitis C. Annals of Hepatology, v. 4, n. 3, p. 176-183, 2005Tradução . . Acesso em: 05 nov. 2024.
APA
Ribeiro, M. de F. G. de S., Gayotto, L. C. da C., Chamone, D. de A. F., & Strauss, E. (2005). Alcoholic intake predisposes to more interface hepatitis in chronic hepatitis C. Annals of Hepatology, 4( 3), 176-183.
NLM
Ribeiro M de FG de S, Gayotto LC da C, Chamone D de AF, Strauss E. Alcoholic intake predisposes to more interface hepatitis in chronic hepatitis C. Annals of Hepatology. 2005 ; 4( 3): 176-183.[citado 2024 nov. 05 ]
Vancouver
Ribeiro M de FG de S, Gayotto LC da C, Chamone D de AF, Strauss E. Alcoholic intake predisposes to more interface hepatitis in chronic hepatitis C. Annals of Hepatology. 2005 ; 4( 3): 176-183.[citado 2024 nov. 05 ]

USP Schools

ReP

Filtros

Authors

Subjects